Search

everythinglearnresearchcommunity

for

Search:↓

Men with early-onset baldness may have a higher risk of heart disease.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Topical finasteride can effectively treat male pattern baldness with fewer side effects than oral use.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The optimized microemulsion with finasteride and cinnamon oil can effectively deliver the drug through the skin without using ethanol.

The new minoxidil lotion using Aloplus Total is stable and can be mixed with other ingredients for treating hair loss.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

New treatments for common hair loss are needed.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Testosterone is made by Leydig cells, is active when not bound to proteins, and works by binding to receptors in muscles and other tissues.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Early hair loss in young males may not be clearly linked to insulin resistance or metabolic syndrome.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.